__timestamp | Ultragenyx Pharmaceutical Inc. | Verona Pharma plc |
---|---|---|
Wednesday, January 1, 2014 | 10811000 | 1802274 |
Thursday, January 1, 2015 | 33001000 | 2512761 |
Friday, January 1, 2016 | 64936000 | 2894488 |
Sunday, January 1, 2017 | 99909000 | 8096274 |
Monday, January 1, 2018 | 127724000 | 7985229 |
Tuesday, January 1, 2019 | 161524000 | 8994597 |
Wednesday, January 1, 2020 | 182933000 | 29772000 |
Friday, January 1, 2021 | 219982000 | 33907000 |
Saturday, January 1, 2022 | 278139000 | 26579000 |
Sunday, January 1, 2023 | 309799000 | 49868547 |
Unleashing insights
In the competitive world of biotechnology, managing operational costs is crucial. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Verona Pharma plc and Ultragenyx Pharmaceutical Inc. from 2014 to 2023. Over this period, Ultragenyx's SG&A expenses surged by nearly 2,800%, reflecting its aggressive expansion and market penetration strategies. In contrast, Verona Pharma's expenses grew by approximately 2,700%, indicating a more measured approach to scaling operations. Notably, in 2023, Ultragenyx's expenses were about six times higher than Verona Pharma's, highlighting the differing scales and strategies of these two companies. This financial snapshot provides a window into how these biotechs allocate resources to support their growth and innovation efforts. As the industry evolves, understanding these financial dynamics becomes essential for investors and stakeholders alike.
Novo Nordisk A/S or Verona Pharma plc: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: Bristol-Myers Squibb Company vs Ultragenyx Pharmaceutical Inc.
Comparing SG&A Expenses: BeiGene, Ltd. vs Ultragenyx Pharmaceutical Inc. Trends and Insights
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Verona Pharma plc
United Therapeutics Corporation vs Ultragenyx Pharmaceutical Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Insmed Incorporated vs Ultragenyx Pharmaceutical Inc. Trends and Insights
Walgreens Boots Alliance, Inc. vs Verona Pharma plc: SG&A Expense Trends
Verona Pharma plc and CymaBay Therapeutics, Inc.: SG&A Spending Patterns Compared
Verona Pharma plc or Catalyst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Verona Pharma plc vs Amphastar Pharmaceuticals, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Verona Pharma plc or Novavax, Inc.
Ultragenyx Pharmaceutical Inc. vs Amphastar Pharmaceuticals, Inc.: SG&A Expense Trends